Nursing home use up with cognitive impairment category

October 1, 2017

(HealthDay)—Nursing home (NH) use increases with increasing cognitive impairment category, according to a study published online Sept. 11 in the Journal of the American Geriatrics Society.

Jane A. Emerson, from the Mayo Clinic in Rochester, Minnesota, and colleagues estimated NH use among 3,545 Mayo Clinic Study of Aging participants (aged 70 to 89 years), assessed as cognitively normal (CN), (MCI), previously unrecognized , or prevalent dementia.

The researchers found that the percentages who died in the year after cognition was assessed were 1, 2.6, 4.2, and 21 percent among those categorized as CN, MCI, previously unrecognized dementia, and prevalent dementia, respectively. The percentages with any NH use were 3.8, 8.7, 19, and 40 percent, respectively, with 27, 38, 120, and 305 median NH days and 7.8, 12, 33, and 100 percent median percentages of NH days/days of observation, respectively. A significantly higher proportion had any NH use for each increase in cognitive impairment category. Individuals with prevalent dementia and any NH use had especially high one-year mortality (30 percent versus 13 percent for those with no NH use). Among those with prevalent dementia, 58 percent of all deaths occurred while an NH resident.

"Reductions in NH use could result from quality alternatives to NH admission, both among persons with MCI and persons with dementia, together with suitable options for end-of-life care among persons with prevalent dementia," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including AbbVie, which partially funded the study.

Explore further: Inappropriate med use high in cognitively impaired seniors

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Inappropriate med use high in cognitively impaired seniors

August 2, 2017
(HealthDay)—Many nursing home residents with cognitive impairment or dementia have potentially inappropriate medication (PIM) use, with PIM use more likely among frail individuals, according to a study published online ...

Low-dose aspirin no aid against cognitive decline

May 9, 2017
(HealthDay)—Low-dose aspirin does not protect against cognitive decline, according to a review published April 20 in the Journal of the American Geriatrics Society.

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia

December 31, 2012
Depression in a group of Medicare recipients ages 65 years and older appears to be associated with prevalent mild cognitive impairment and an increased risk of dementia, according to a report published Online First by Archives ...

Research finds increased risk of dementia in patients who experience delirium after surgery

July 28, 2017
Delirium is common in elderly hospitalized patients, affecting an estimated 14 - 56% of patients. It frequently manifests as a sudden change in behavior, with patients suffering acute confusion, inattention, disorganized ...

Review links albuminuria to cognitive impairment, dementia

February 13, 2017
(HealthDay)—Albuminuria is associated with cognitive impairment, dementia, and cognitive decline, according to a review published online Feb. 2 in the Journal of the American Geriatrics Society.

Recommended for you

Energy storehouses in the brain may be source of Alzheimer's, targets of new therapy

January 23, 2018
Alzheimer's disease, a severely debilitating and ultimately fatal brain disorder, affects millions worldwide. To date, clinical efforts to find a cure or adequate treatment have met with dispiriting failure.

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.